Annual FCF
-$24.50 M
+$13.07 M+34.79%
31 December 2023
Summary:
Achieve Life Sciences annual free cash flow is currently -$24.50 million, with the most recent change of +$13.07 million (+34.79%) on 31 December 2023. During the last 3 years, it has fallen by -$11.01 million (-81.60%). ACHV annual FCF is now -170.28% below its all-time high of $34.86 million, reached on 31 December 2009.ACHV Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$10.37 M
-$5.45 M-110.77%
30 September 2024
Summary:
Achieve Life Sciences quarterly free cash flow is currently -$10.37 million, with the most recent change of -$5.45 million (-110.77%) on 30 September 2024. Over the past year, it has dropped by -$5.22 million (-101.36%). ACHV quarterly FCF is now -123.51% below its all-time high of $44.11 million, reached on 31 December 2009.ACHV Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$24.95 M
-$5.22 M-26.46%
30 September 2024
Summary:
Achieve Life Sciences TTM free cash flow is currently -$24.95 million, with the most recent change of -$5.22 million (-26.46%) on 30 September 2024. Over the past year, it has increased by +$6.32 million (+20.22%). ACHV TTM FCF is now -171.57% below its all-time high of $34.86 million, reached on 31 December 2009.ACHV TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACHV Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +34.8% | -101.4% | +20.2% |
| 3 y3 years | -81.6% | -19.3% | +6.6% |
| 5 y5 years | -129.6% | -237.6% | -62.0% |
ACHV Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -81.6% | +34.8% | -137.3% | +8.3% | -26.5% | +36.2% |
| 5 y | 5 years | -129.6% | +34.8% | -369.3% | +8.3% | -89.6% | +36.2% |
| alltime | all time | -170.3% | +44.0% | -123.5% | +39.6% | -171.6% | +47.1% |
Achieve Life Sciences Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$10.37 M(+110.8%) | -$24.95 M(+26.5%) |
| June 2024 | - | -$4.92 M(-6.9%) | -$19.73 M(-8.2%) |
| Mar 2024 | - | -$5.29 M(+21.0%) | -$21.48 M(-12.3%) |
| Dec 2023 | -$24.50 M(-34.8%) | -$4.37 M(-15.2%) | -$24.50 M(-21.7%) |
| Sept 2023 | - | -$5.15 M(-22.8%) | -$31.27 M(-16.4%) |
| June 2023 | - | -$6.68 M(-19.6%) | -$37.43 M(-4.3%) |
| Mar 2023 | - | -$8.30 M(-25.5%) | -$39.09 M(+4.1%) |
| Dec 2022 | -$37.57 M(+27.6%) | -$11.14 M(-1.5%) | -$37.57 M(+18.7%) |
| Sept 2022 | - | -$11.31 M(+35.6%) | -$31.64 M(+9.0%) |
| June 2022 | - | -$8.34 M(+23.0%) | -$29.03 M(-2.5%) |
| Mar 2022 | - | -$6.78 M(+29.9%) | -$29.77 M(+1.1%) |
| Dec 2021 | -$29.44 M(+118.2%) | -$5.22 M(-40.0%) | -$29.44 M(+10.3%) |
| Sept 2021 | - | -$8.69 M(-4.2%) | -$26.70 M(+19.5%) |
| June 2021 | - | -$9.08 M(+40.7%) | -$22.35 M(+44.4%) |
| Mar 2021 | - | -$6.45 M(+160.2%) | -$15.48 M(+14.7%) |
| Dec 2020 | -$13.49 M(-11.6%) | -$2.48 M(-42.8%) | -$13.49 M(-6.5%) |
| Sept 2020 | - | -$4.34 M(+96.3%) | -$14.43 M(+9.6%) |
| June 2020 | - | -$2.21 M(-50.5%) | -$13.16 M(-11.0%) |
| Mar 2020 | - | -$4.46 M(+30.7%) | -$14.79 M(-3.1%) |
| Dec 2019 | -$15.27 M(+43.1%) | -$3.42 M(+11.2%) | -$15.27 M(-0.9%) |
| Sept 2019 | - | -$3.07 M(-20.0%) | -$15.40 M(+0.6%) |
| June 2019 | - | -$3.84 M(-22.3%) | -$15.31 M(+14.5%) |
| Mar 2019 | - | -$4.94 M(+39.2%) | -$13.38 M(+25.4%) |
| Dec 2018 | -$10.67 M(+17.2%) | -$3.55 M(+19.1%) | -$10.67 M(-0.7%) |
| Sept 2018 | - | -$2.98 M(+56.6%) | -$10.74 M(-18.7%) |
| June 2018 | - | -$1.90 M(-14.7%) | -$13.21 M(+16.6%) |
| Mar 2018 | - | -$2.23 M(-38.4%) | -$11.33 M(+24.4%) |
| Dec 2017 | -$9.11 M(+4408.4%) | -$3.62 M(-33.6%) | -$9.11 M(-153.4%) |
| Sept 2017 | - | -$5.46 M(>+9900.0%) | $17.06 M(+11.9%) |
| June 2017 | - | -$18.00 K(+63.6%) | $15.24 M(+71.8%) |
| Mar 2017 | - | -$11.00 K(-100.0%) | $8.87 M(-4493.1%) |
| Dec 2016 | -$202.00 K(-97.9%) | $22.54 M(-410.2%) | -$202.00 K(-99.4%) |
| Sept 2016 | - | -$7.27 M(+13.7%) | -$33.50 M(-4.0%) |
| June 2016 | - | -$6.39 M(-29.7%) | -$34.90 M(+193.0%) |
| Mar 2016 | - | -$9.09 M(-15.5%) | -$11.91 M(+25.7%) |
| Dec 2015 | -$9.47 M(-45.5%) | -$10.76 M(+24.1%) | -$9.47 M(+67.3%) |
| Sept 2015 | - | -$8.67 M(-152.2%) | -$5.66 M(+104.6%) |
| June 2015 | - | $16.60 M(-349.7%) | -$2.77 M(-87.6%) |
| Mar 2015 | - | -$6.65 M(-4.3%) | -$22.34 M(+28.5%) |
| Dec 2014 | -$17.39 M(-51.9%) | -$6.95 M(+20.3%) | -$17.39 M(-3.4%) |
| Sept 2014 | - | -$5.77 M(+94.2%) | -$18.00 M(-19.9%) |
| June 2014 | - | -$2.97 M(+74.9%) | -$22.47 M(-17.0%) |
| Mar 2014 | - | -$1.70 M(-77.5%) | -$27.08 M(-25.2%) |
| Dec 2013 | -$36.18 M(-17.4%) | -$7.56 M(-26.2%) | -$36.18 M(-5.5%) |
| Sept 2013 | - | -$10.24 M(+35.1%) | -$38.30 M(-6.6%) |
| June 2013 | - | -$7.58 M(-29.8%) | -$41.02 M(-13.1%) |
| Mar 2013 | - | -$10.80 M(+11.6%) | -$47.20 M(+7.8%) |
| Dec 2012 | -$43.78 M(+115.2%) | -$9.67 M(-25.4%) | -$43.78 M(+13.6%) |
| Sept 2012 | - | -$12.96 M(-5.9%) | -$38.55 M(+21.3%) |
| June 2012 | - | -$13.77 M(+86.5%) | -$31.79 M(+34.4%) |
| Mar 2012 | - | -$7.38 M(+66.2%) | -$23.65 M(+16.3%) |
| Dec 2011 | -$20.34 M(-24.4%) | -$4.44 M(-28.3%) | -$20.34 M(+3.6%) |
| Sept 2011 | - | -$6.20 M(+10.2%) | -$19.64 M(+4.3%) |
| June 2011 | - | -$5.62 M(+38.0%) | -$18.82 M(+36.3%) |
| Mar 2011 | - | -$4.08 M(+8.9%) | -$13.81 M(-48.7%) |
| Dec 2010 | -$26.91 M | -$3.74 M(-30.5%) | -$26.91 M(-228.5%) |
| Sept 2010 | - | -$5.38 M(+776.9%) | $20.95 M(-11.4%) |
| June 2010 | - | -$614.00 K(-96.4%) | $23.65 M(+14.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | -$17.17 M(-138.9%) | $20.74 M(-40.5%) |
| Dec 2009 | $34.86 M(-383.2%) | $44.11 M(-1743.0%) | $34.86 M(-346.4%) |
| Sept 2009 | - | -$2.69 M(-23.6%) | -$14.15 M(+78.1%) |
| June 2009 | - | -$3.52 M(+15.3%) | -$7.95 M(-20.2%) |
| Mar 2009 | - | -$3.05 M(-37.8%) | -$9.96 M(-19.1%) |
| Dec 2008 | -$12.31 M(-50.2%) | -$4.90 M(-239.2%) | -$12.31 M(-11.8%) |
| Sept 2008 | - | $3.52 M(-163.6%) | -$13.95 M(-34.1%) |
| June 2008 | - | -$5.53 M(+2.4%) | -$21.17 M(+2.7%) |
| Mar 2008 | - | -$5.40 M(-17.4%) | -$20.62 M(-16.6%) |
| Dec 2007 | -$24.73 M(+20.8%) | -$6.54 M(+76.5%) | -$24.73 M(+16.5%) |
| Sept 2007 | - | -$3.70 M(-25.6%) | -$21.22 M(-10.7%) |
| June 2007 | - | -$4.98 M(-47.7%) | -$23.77 M(-16.8%) |
| Mar 2007 | - | -$9.51 M(+213.6%) | -$28.58 M(+39.6%) |
| Dec 2006 | -$20.47 M(+141.4%) | -$3.03 M(-51.5%) | -$20.47 M(+85.7%) |
| Sept 2006 | - | -$6.25 M(-36.2%) | -$11.02 M(+6.2%) |
| June 2006 | - | -$9.79 M(+598.7%) | -$10.38 M(+134.0%) |
| Mar 2006 | - | -$1.40 M(-121.8%) | -$4.44 M(-47.7%) |
| Dec 2005 | -$8.48 M(-43.7%) | $6.42 M(-214.4%) | -$8.48 M(-56.0%) |
| Sept 2005 | - | -$5.61 M(+45.9%) | -$19.28 M(+10.4%) |
| June 2005 | - | -$3.84 M(-29.4%) | -$17.46 M(+4.0%) |
| Mar 2005 | - | -$5.44 M(+24.1%) | -$16.80 M(+11.6%) |
| Dec 2004 | -$15.05 M(+42.0%) | -$4.39 M(+15.7%) | -$15.05 M(+8.2%) |
| Sept 2004 | - | -$3.79 M(+19.3%) | -$13.90 M(+11.7%) |
| June 2004 | - | -$3.18 M(-13.9%) | -$12.44 M(+5.0%) |
| Mar 2004 | - | -$3.69 M(+13.9%) | -$11.85 M(+11.8%) |
| Dec 2003 | -$10.60 M(-6.3%) | -$3.24 M(+39.0%) | -$10.60 M(+7.4%) |
| Sept 2003 | - | -$2.33 M(-9.7%) | -$9.87 M(-5.6%) |
| June 2003 | - | -$2.58 M(+5.7%) | -$10.45 M(-6.1%) |
| Mar 2003 | - | -$2.44 M(-2.7%) | -$11.12 M(-1.6%) |
| Dec 2002 | -$11.30 M(-1165.3%) | -$2.51 M(-13.8%) | -$11.30 M(+5.0%) |
| Sept 2002 | - | -$2.91 M(-10.6%) | -$10.77 M(+175.6%) |
| June 2002 | - | -$3.26 M(+24.0%) | -$3.91 M(+299.9%) |
| Mar 2002 | - | -$2.63 M(+33.0%) | -$977.20 K(-192.1%) |
| Dec 2001 | $1.06 M(-126.4%) | -$1.97 M(-150.0%) | $1.06 M(-6.2%) |
| Sept 2001 | - | $3.95 M(-1312.3%) | $1.13 M(-123.2%) |
| June 2001 | - | -$325.70 K(-44.6%) | -$4.88 M(+96.9%) |
| Mar 2001 | - | -$587.50 K(-69.2%) | -$2.48 M(-38.2%) |
| Dec 2000 | -$4.01 M(+2677.0%) | -$1.90 M(-7.8%) | -$4.01 M(+945.5%) |
| Sept 2000 | - | -$2.06 M(-199.4%) | -$383.80 K(-103.4%) |
| June 2000 | - | $2.08 M(-198.0%) | $11.21 M(-1262.6%) |
| Mar 2000 | - | -$2.12 M(-222.9%) | -$964.40 K(+567.4%) |
| Dec 1999 | -$144.50 K(-98.7%) | $1.72 M(-81.9%) | -$144.50 K(-97.2%) |
| Sept 1999 | - | $9.53 M(-194.4%) | -$5.17 M(-67.7%) |
| June 1999 | - | -$10.10 M(+676.9%) | -$16.00 M(+86.0%) |
| Mar 1999 | - | -$1.30 M(-60.6%) | -$8.60 M(-20.4%) |
| Dec 1998 | -$10.80 M(-5500.0%) | -$3.30 M(+153.8%) | -$10.80 M(+40.3%) |
| Sept 1998 | - | -$1.30 M(-51.9%) | -$7.70 M(+2.7%) |
| June 1998 | - | -$2.70 M(-22.9%) | -$7.50 M(+102.7%) |
| Mar 1998 | - | -$3.50 M(+1650.0%) | -$3.70 M(-1950.0%) |
| Dec 1997 | $200.00 K(-93.3%) | -$200.00 K(-81.8%) | $200.00 K(-94.4%) |
| Sept 1997 | - | -$1.10 M(-200.0%) | $3.60 M(-53.2%) |
| June 1997 | - | $1.10 M(+175.0%) | $7.70 M(+5.5%) |
| Mar 1997 | - | $400.00 K(-87.5%) | $7.30 M(+143.3%) |
| Dec 1996 | $3.00 M(-137.0%) | $3.20 M(+6.7%) | $3.00 M(-1600.0%) |
| Sept 1996 | - | $3.00 M(+328.6%) | -$200.00 K(-93.8%) |
| June 1996 | - | $700.00 K(-117.9%) | -$3.20 M(-17.9%) |
| Mar 1996 | - | -$3.90 M | -$3.90 M |
| Dec 1995 | -$8.10 M(+92.9%) | - | - |
| Dec 1994 | -$4.20 M | - | - |
FAQ
- What is Achieve Life Sciences annual free cash flow?
- What is the all time high annual FCF for Achieve Life Sciences?
- What is Achieve Life Sciences annual FCF year-on-year change?
- What is Achieve Life Sciences quarterly free cash flow?
- What is the all time high quarterly FCF for Achieve Life Sciences?
- What is Achieve Life Sciences quarterly FCF year-on-year change?
- What is Achieve Life Sciences TTM free cash flow?
- What is the all time high TTM FCF for Achieve Life Sciences?
- What is Achieve Life Sciences TTM FCF year-on-year change?
What is Achieve Life Sciences annual free cash flow?
The current annual FCF of ACHV is -$24.50 M
What is the all time high annual FCF for Achieve Life Sciences?
Achieve Life Sciences all-time high annual free cash flow is $34.86 M
What is Achieve Life Sciences annual FCF year-on-year change?
Over the past year, ACHV annual free cash flow has changed by +$13.07 M (+34.79%)
What is Achieve Life Sciences quarterly free cash flow?
The current quarterly FCF of ACHV is -$10.37 M
What is the all time high quarterly FCF for Achieve Life Sciences?
Achieve Life Sciences all-time high quarterly free cash flow is $44.11 M
What is Achieve Life Sciences quarterly FCF year-on-year change?
Over the past year, ACHV quarterly free cash flow has changed by -$5.22 M (-101.36%)
What is Achieve Life Sciences TTM free cash flow?
The current TTM FCF of ACHV is -$24.95 M
What is the all time high TTM FCF for Achieve Life Sciences?
Achieve Life Sciences all-time high TTM free cash flow is $34.86 M
What is Achieve Life Sciences TTM FCF year-on-year change?
Over the past year, ACHV TTM free cash flow has changed by +$6.32 M (+20.22%)